Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diet vs Otilonium Bromide in Irritable Bowel Syndrome
NCT04270487Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of otilonium in irritable bowel syndrome (IBS), sponsored by UZ Leuven. Started Jul 2018; status: completed.
02
Drugs
otilonium
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04270487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04270487.